Latest Pharmacology Stories
Repeat Brand of the Year Awards For TUMS, Vicks, FiberCon, Tylenol PM and Walgreens; Dulcolax and Tylenol Pain Reliever are at the top of their respective categories for the first time NEW YORK, June 13, 2013 /PRNewswire/ -- The rise of medical and health information websites has led to an increased number of consumers accessing unlimited quantities of information, studies and diagnoses. This growth of health-focused websites has created competition, with some well-known brands...
Evaluate to Launch World Preview 2013 Edition at Drug Information Association (DIA) Annual Meeting LONDON and BOSTON, June 13, 2013 /PRNewswire/ -- Patent expirations in 2012 have put the industry through an unprecedented decline in worldwide prescription drug sales in 2012. Now that the pharmaceutical industry has faced the biggest patent cliff it has ever seen, Evaluate Ltd. will examine its effects and what the industry can expect through 2018 in its upcoming annual World...
FALLS CHURCH, Va., June 13, 2013 /PRNewswire-iReach/ -- Clinical Trials Disclosure and Transparency Summit**Presented by FDAnews**July 23-24, 2013 - Bethesda, MDwww.fdanews.com/ClinicalTrialDisclosure (Photo: http://photos.prnewswire.com/prnh/20130613/CG31191) Register NOW and find out what you need to know and do to handle the FDA and EMA's new stepped-up enforcement of Clinical Trial Disclosure requirements ... Discover best practices for meeting current disclosure...
- CRO leaders exhibiting and speaking at the 49th Annual Meeting in Boston - SAN DIEGO, June 13, 2013 /PRNewswire/ -- SynteractHCR, a leading full-service global contract research organization (CRO), will unveil its Intelligent Clinical Development platform (ICD+) at the 49(th) Drug Information Association (DIA) annual meeting, June 23-27 in Boston at the Boston Convention & Exhibition Center. SynteractHCR will exhibit at booth #819. (Logo:...
BOULDER, Colo., June 13, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities Research and Economics 2013 Healthcare Conference in Boston. The public is welcome to participate in the conference through a webcast on the Array BioPharma website. (Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO) Event: Wells Fargo Securities Research and Economics...
Other types of "vending" machines will be prohibited HOLLYWOOD, Calif., June 13, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry-specific consulting services and patented systems to medical and retail businesses worldwide, announced that proposed modifications to San Diego's medical marijuana ordinance has been released to the public. In summary, the proposed legislation would permit Medbox systems, and prohibit other types...
NESS ZIONA, Israel, June 13, 2013 /PRNewswire/ -- NeuroDerm, Ltd. today announced that abstracts reporting results from a phase I study in healthy volunteers, and preliminary results from a phase IIA study in advanced Parkinson's patients, of ND0612, have been selected for presentation at the 17th International Congress of Parkinson's Disease and Movement Disorders, June 16th-20th in Sydney, Australia. ND0612 is a proprietary levodopa/carbidopa liquid drug formula under...
Gulf Coast Addiction Treatment is an alcohol and drug recovery facility with a hands-on approach to recovery that offers assistance every step of the way. That assistance extends to the abuse and dependency of alcohol and all types of drugs, inclusive of the increasingly common abuse of Adderall. Destin, FL (PRWEB) June 12, 2013 Gulf Coast Addiction Treatment has seen an increase of people seeking help for Adderall abuse and addiction, which is an issue that often crops up on college...
Neurological Wellness Center physician's group seeks sponsors for pilot study to evaluate the efficacy of perispinally administered Stelara as an Alzheimer's treatment. (PRWEB) June 12, 2013 Currently clinical trials are ongoing in the U.S., Nicaragua and U.K. to evaluate the efficacy of the FDA approved psoriasis drug Enbrel as an Alzheimer's treatment.* Similar clinical trials are needed to evaluate the efficacy of the FDA approved psoriasis drug Stelara as an...
MADRID, June 13, 2013 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced the results from the CONCERTO trial, the first randomized, controlled trial assessing different predefined doses of methotrexate (MTX) in combination with HUMIRA® (adalimumab) for the treatment of moderate to severe rheumatoid arthritis (RA). CONCERTO shows that at week 26 of treatment, a statistically significant increasing trend was observed in the proportion of patients achieving low disease activity with an...
Latest Pharmacology Reference Libraries
The European Journal of Medical Chemistry is a peer-reviewed scientific journal for medical chemistry. It is published by Elsevier. It was established in 1966 under the title Chimica Therapeutica. That name was maintained until 1973. Even after changing to its current name in 1974, the journal was still subtitled Chimica Therapeutica until 1981; from 1982 to 1986 it was subtitled Chimie Therapeutique, indicating its French origin. The Journal publishes studies on all aspects of medicinal...
Bursera graveolens or Palo Santo is a tree indigenous to South America in Argetina, Paraguay, Boliva and coastal areas of Ecuador. Palo Santo means "holy wood" in English and belongs in the same family as frankincense and myrrh. Although it has been used in homeopathic medicine for years, most recently it is the extraction of essential oils that has put this plant in the spotlight. Limonene, a-Terpineol, Menthofuran and Carvone are a few of the oils derived from this plant. Native...
Datura wrightii (a poisonous weed) is sometimes used as a hallucinogen. It is commonly called Sacred Datura. Datura wrightii is classified as a deliriant, or an anticholinergic. In the US it is, however, called Western Jimson Weed.
